Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies.
Pietsch, E.C., Dong, J., Cardoso, R., Zhang, X., Chin, D., Hawkins, R., Dinh, T., Zhou, M., Strake, B., Feng, P.H., Rocca, M., Santos, C.D., Shan, X., Danet-Desnoyers, G., Shi, F., Kaiser, E., Millar, H.J., Fenton, S., Swanson, R., Nemeth, J.A., Attar, R.M.(2017) Blood Cancer J 7: e536-e536
- PubMed: 28234345 
- DOI: 10.1038/bcj.2017.7
- Primary Citation of Related Structures:  
5TZ2, 5TZT, 5TZU - PubMed Abstract: 
CD47, a broadly expressed cell surface protein, inhibits cell phagocytosis via interaction with phagocyte-expressed SIRPα. A variety of hematological malignancies demonstrate elevated CD47 expression, suggesting that CD47 may mediate immune escape. W ...